Host defense peptides as immunomodulators: The other side of the coin

• Published in: Peptides (New York, N.Y. : 1980) Vol. 146; p. 170644
• Main Authors: Martell, Ernesto M., González-Garcia, Melaine, Ständker, Ludger, Otero-González, Anselmo J.
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01-12-2021
• Subjects: Animals; Anti-Infective Agents - pharmacology; Antimicrobial Cationic Peptides - pharmacology; Host Defense Peptides; Humans; Immune System - drug effects; Immunologic Factors - pharmacology; Immunomodulation; Innate immunity; Host Defense Peptides; Immunomodulation; Innate immunity
• ISSN: 0196-9781; 1873-5169
• DOI: 10.1016/j.peptides.2021.170644

Host defense peptides (HDPs) exhibit a broad range of antimicrobial and immunomodulatory activities. In this sense, both functions are like different sides of the same coin. The direct antimicrobial side was discovered first, and widely studied for the development of anti-infective therapies. In contrast, the immunomodulatory side was recognized later and in the last 20 years the interest in this field has been continuously growing. Different to their antimicrobial activities, the immunomodulatory activities of host defense peptides are more effective in vivo. They offer a great opportunity for new therapeutic applications in the fields of anti-infective therapy, chronic inflammatory diseases treatment, novel vaccine adjuvants development and anticancer immunotherapy. These immune related functions of HDPs includes chemoattraction of leukocytes, modulation of inflammation, enhancement of antigen presentation and polarization of adaptive immune responses. Our attempt with this review is to make a careful evaluation of different aspects of the less explored, but attractive immunomodulatory side of the HDP functional coin.